121 – 130 of 140
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 1997
-
Mark
Evaluation of original and modified APC-resistance tests in unselected outpatients with clinically suspected thrombosis and in healthy controls
(
- Contribution to journal › Article
-
Mark
A common thrombomodulin amino acid dimorphism is associated with myocardial infarction
(
- Contribution to journal › Article
-
Mark
Human tissue factor pathway inhibitor fused to CD4 binds both FXa and TF/FVIIa at the cell surface
(
- Contribution to journal › Article
- 1996
-
Mark
Experimental haemorrhagic effect of two-domain non-glycosylated tissue factor pathway inhibitor compared to low molecular weight heparin
(
- Contribution to journal › Article
-
Mark
Elevated levels of prothrombin activation fragment 1 + 2 in plasma from patients with heterozygous Arg506 to Gln mutation in the factor V gene (APC-resistance) and/or inherited protein S deficiency
(
- Contribution to journal › Article
- 1995
-
Mark
Homozygous APC-resistance combined with inherited type I protein S deficiency in a young boy with severe thrombotic disease
(
- Contribution to journal › Article
- 1994
-
Mark
Study of the interaction of dextran and enoxaparin on haemostasis in humans
(
- Contribution to journal › Article
-
Mark
Effect of low molecular weight heparin, dextran and their combinations on experimental venous thrombosis in rabbits
(
- Contribution to journal › Article
-
Mark
High titer inhibitors in severe haemophilia A. A meta-analysis based on eight long-term follow-up studies concerning inhibitors associated with crude or intermediate purity factor VIII products [4]
(
- Contribution to journal › Letter
-
Mark
Antithrombotic effect of recombinant truncated tissue factor pathway inhibitor (TFPI1-161) in experimental venous thrombosis : A comparison with low molecular weight heparin
(
- Contribution to journal › Article